Josep M. Campistol

Research interests

Publications

• Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network

  Cell stem cell · 2019 · https://doi.org/10.1016/j.stem.2019.06.009

• Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells

  Nature Materials · 2019 · https://doi.org/10.1038/s41563-019-0287-6

• The copy number variation landscape of congenital anomalies of the kidney and urinary tract

  Nature Genetics · 2018 · https://doi.org/10.1038/s41588-018-0281-y

• Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

  New England Journal of Medicine · 2018 · 10.1056/nejmoa1716153

• Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

  New England Journal of Medicine · 2018 · 10.1056/nejmoa1716793

• The complete European guidelines on phenylketonuria: diagnosis and treatment

  Orphanet Journal of Rare Diseases · 2017 · 10.1186/s13023-017-0685-2

• Interspecies Chimerism with Mammalian Pluripotent Stem Cells

  Cell · 2017 · https://doi.org/10.1016/j.cell.2016.12.036

• Tissue engineering by decellularization and 3D bioprinting

  Materials Today · 2017 · https://doi.org/10.1016/j.mattod.2016.12.005

• In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation

  Cell · 2017 · https://doi.org/10.1016/j.cell.2017.10.025

• In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming

  Cell · 2016 · 10.1016/j.cell.2016.11.052

• In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration

  Nature · 2016 · https://doi.org/10.1038/nature20565

• Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial

  American Journal of Kidney Diseases · 2016 · 10.1053/j.ajkd.2015.12.034

• Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso

  Nefrología · 2015 · 10.1016/j.nefro.2015.07.005

• Selective Elimination of Mitochondrial Mutations in the Germline by Genome Editing

  Cell · 2015 · https://doi.org/10.1016/j.cell.2015.03.051

• An alternative pluripotent state confers interspecies chimaeric competency

  Nature · 2015 · https://doi.org/10.1038/nature14413

• Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

  Orphanet Journal of Rare Diseases · 2015 · 10.1186/s13023-015-0326-6

• In Vivo Activation of a Conserved MicroRNA Program Induces Mammalian Heart Regeneration

  Cell stem cell · 2014 · https://doi.org/10.1016/j.stem.2014.10.003

• Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells

  Nature Cell Biology · 2013 · https://doi.org/10.1038/ncb2872

• High-Efficiency Postdilution Online Hemodiafiltration Reduces All-Cause Mortality in Hemodialysis Patients

  Journal of the American Society of Nephrology · 2013 · 10.1681/asn.2012080875

• Sensitivity of Blood Volume Monitoring for Fluid Status Assessment in Hemodialysis Patients

  Blood Purification · 2013 · 10.1159/000346630

• Tafamidis for transthyretin familial amyloid polyneuropathy

  Neurology · 2012 · 10.1212/wnl.0b013e3182661eb1

• Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation

  New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1204166

• Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)

  American Journal of Transplantation · 2010 · 10.1111/j.1600-6143.2010.03016.x

• Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial

  Transplantation · 2009 · 10.1097/tp.0b013e3181927a41

• Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients

  Drugs · 2007 · 10.2165/00003495-200767080-00006

• Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

  American Journal of Transplantation · 2007 · https://doi.org/10.1111/j.1600-6143.2007.01749.x

• Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal Transplantation

  Journal of the American Society of Nephrology · 2006 · 10.1681/asn.2005090993

• SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12

  Transplantation · 2000 · 10.1097/00007890-200004150-00009

• SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION

  Transplantation · 1999 · 10.1097/00007890-199904150-00017

Current projects

No projects listed.